My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Vericel Corporation - Common Stock (NQ:VCEL)

35.96 +1.99 (+5.86%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Vericel Corporation - Common Stock

< Previous 1 2 3 4 Next >

Earnings Preview For Vericel ↗

November 06, 2024

Via Benzinga

The Analyst Verdict: Vericel In The Eyes Of 7 Experts ↗

August 27, 2024

Via Benzinga

Expert Ratings For Vericel ↗

August 09, 2024

Via Benzinga

The Latest Analyst Ratings For Vericel ↗

August 02, 2024

Via Benzinga

Apple To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Friday ↗

August 02, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Vericel Through 4 Analysts ↗

July 16, 2024

Via Benzinga

Trading SMID Biotech Stocks In A Volatile Market ↗

July 01, 2024

Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...

Via Talk Markets

Critical Insights From Vericel Analyst Ratings: What You Need To Know ↗

May 09, 2024

Via Benzinga

Analyst Scoreboard: 5 Ratings For Vericel ↗

March 26, 2024

Via Benzinga

The 3 Highest-Rated Medical Stocks You Can Buy Today ↗

June 27, 2024

Are you looking for highly-rated medical stocks? These three contenders are offering substantial growth over the long term.

Via InvestorPlace

VCEL Stock Earnings: Vericel Beats EPS, Beats Revenue for Q1 2024 ↗

May 08, 2024

VCEL stock results show that Vericel beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility ↗

March 11, 2024

Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.

Via Talk Markets

A Closer Look at 4 Analyst Recommendations For Vericel ↗

March 01, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

3 Top Pharma Stocks for Investors Betting on a Biotech Boom ↗

February 26, 2024

Pharma stocks offer phenomenal returns when their drug gets approved. Here are three stocks that could soar in 2024.

Via InvestorPlace

HC Wainwright & Co. Maintains Buy Rating for Vericel: Here's What You Need To Know ↗

January 16, 2024

Via Benzinga

Analyst Ratings for Vericel ↗

October 16, 2023

Via Benzinga

Analyst Ratings for Vericel ↗

September 21, 2023

Via Benzinga

Expert Ratings for Vericel ↗

August 03, 2023

Via Benzinga

Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development ↗

December 28, 2023

Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S.

Via Benzinga

3 Biotech Stocks That Could Boom or Bust by 2025 ↗

November 16, 2023

Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday.

Via InvestorPlace

3 Strong Buy Stocks Set to Take Off in the Coming Months ↗

November 10, 2023

These 3 strong buy stocks have industry experts' positive outlook and seal of approval. The only question is, are you in?

Via InvestorPlace

Vericel's Short Report: Deep Dive Into Knee-Repair Focused Company's 27 Years of Losses ↗

September 20, 2023

J Capital Research has released a short idea report on Vericel Corporation (NASDAQ:

Via Benzinga

As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs ↗

August 29, 2023

Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.

Via Benzinga

Vericel: Q1 Earnings Insights ↗

May 10, 2023

Via Benzinga

Vericel Earnings Perspective: Return On Capital Employed ↗

February 28, 2023

Via Benzinga

Analyst Expectations for Vericel's Future ↗

February 27, 2023

Via Benzinga

Earnings Scheduled For November 8, 2023 ↗

November 08, 2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗

August 08, 2023

Via Benzinga

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.